ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Outcome"

  • 2016 American Transplant Congress

    Complications of Dual Antiplatelet Therapy Among Recipients of Kidney Transplants.

    F. Weng, A. Athavale, K. Hussain, K. Tibaldi, G. Rogal.

    Saint Barnabas Medical Center, Livingston, NJ.

    Introduction: For patients undergoing percutanous coronary intervention (PCI) with drug-eluting stents, dual antiplatelet therapy (DAPT) is often used to prevent stent thrombosis. Kidney transplantation of…
  • 2016 American Transplant Congress

    Intraoperative Blood Loss Is a Promoter of Early Tumor Recurrence in Liver Transplant Patients with High Risk Hepatocellular Carcinoma.

    A. Kornberg,1 U. Witt,1 J. Kornberg,2 H. Friess,1 K. Müller,3 K. Thrum.4

    1Surgery, Technical University, Munich, Germany; 2Anesthesiology, Ludwig-Maximilians-University, Munich, Germany; 3FSU, Jena, Germany; 4Pathology, Helios-Klinikum, Berlin, Germany.

    Background:Currently, there is an increasing body of evidence that risk of early hepatocellular carcinoma (HCC) relapse following liver transplantation (LT) may be promoted by mechanisms…
  • 2016 American Transplant Congress

    Kidney Transplant Patient Preferences and Trade-Offs for Outcomes After Transplantation.

    M. Howell,1,2 G. Wong,1,2,3 J. Rose,4 A. Tong,1,2 J. Craig,1,2 K. Howard.2

    1Centre for Kidney Research, The Childrens Hospital at Westmead, Westmead, NSW, Australia; 2School of Public Health, University of Sydney, Sydney, NSW, Australia; 3Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia; 4Institute of Choice, University of South Australia, North Sydney, NSW, Australia.

    Aim: To evaluate preferences and trade-offs patients may accept to avoid adverse outcomes of long-term immunosuppression. Background: Patient preferences in clinical decisions are increasingly relevant,…
  • 2016 American Transplant Congress

    The Role of Short-Term Ventricular Assist Device in Patients with Cardiogenic Shock – Is It Really a Solution?

    A. Popov, M. Zeriouh, S. Anton, W. Alexander, Z. Bartlomiej, D. Garcia, P. Mohite, A. Padukone, A. Koch, O. Ananiadou, L. Fazekas, A. Simon.

    Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom.

    Background: Low cardiac output syndrome is associated with significant mortality. In patients with refractory low cardiac output left ventricular assist devices (VAD) are used to…
  • 2016 American Transplant Congress

    Strategies to Prevent Ischemic Cholangiopathy After Donation After Circulatory Death Donor Liver Transplantation.

    C. Kubal,1 R. Mangus,1 J. Fridell,1 B. Ekser,1 N. Rush,2 R. Saxena,2 J. Tector.1

    1Department of Surgery, Indiana University School of Medicine, Indianapolis, IN; 2Department of Pathology, Indiana University School of Medicine, Indianapolis, IN.

    Background: Donation after circulatory death (DCD) donor pool remains underutilized for liver transplantation (LT). We describe optimizing the “modifiable risk factors”, such as CIT, recipient…
  • 2016 American Transplant Congress

    Effect of Baseline Co-Morbidity on Mortality in Living Kidney Donors – 10 Year UK Cohort Study.

    N. Krishnan,1 L. Bradbury,2 N. Raymond.1

    1Renal & Transplantation, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, United Kingdom; 2Statistics, National Health Service, Organ Donation & Transplant, Bristol, United Kingdom.

    Living kidney donation has significantly improved recipient and graft survival world wide. With a move to increase these numbers further, it becomes mandatory to have…
  • 2016 American Transplant Congress

    Combined Liver-Kidney Transplantation for Polycystic Liver and Kidney Disease: Analysis from the UNOS Dataset.

    C. Coquillard, J. Berger, M. Daily, X. Mei, F. Marti, M. Shah, R. Gedaly.

    Surgery, University of Kentucky, Lexington.

    Background: The purpose of this study was to evaluate predictors of outcomes in combined liver-kidney (L/K) transplants for PLD/PKD.Methods: We queried the UNOS dataset for…
  • 2016 American Transplant Congress

    Early Tacrolimus Exposure in Patients Treated De Novo with Once-Daily Tacrolimus After Liver Transplantation: Relationship with Acute Rejection and Long-Term Outcome.

    M. Gastaca, A. Valdivieso, J. Bustamante, P. Ruiz, J. Fernandez, A. Ventoso, M. Testillano, I. Palomares, M. Prieto, P. Salvador, A. Matarranz, M. Suarez, J. Ortiz de Urbina.

    Liver Transplantation Unit, Cruces University Hospital, Bilbao, Vizcaya, Spain.

    AIM: The aim of our study was to define the possible influence of early tacrolimus exposure on long-term outcomes in patients treated with de novo…
  • 2016 American Transplant Congress

    A Multidisciplinary Approach to Reviewing Patient Care in Abdominal Transplantation.

    S. Lerner, M. Resta-Flarer, R. Shapiro, S. Florman, L. Kim-Schluger, V. Nair.

    Mount Sinai Hospital, New York, NY.

    Purpose: Unbiased review of patient care in solid organ transplantation is difficult but essential for improving patient safety. In October 2013 we created a process…
  • 2016 American Transplant Congress

    Skipping Comparable Local Waitlist Candidates Under Share 35.

    E. Chow,1 A. Massie,1 X. Luo,1 C. Wickliffe,1 S. Gentry,2 A. Cameron,1 D. Segev.1

    1Surgery, Johns Hopkins University, Baltimore, MD; 2Mathematics, US Naval Academy, Annapolis, MD.

    Under Share-35, deceased donor (DD) livers are offered regionally to candidates with MELD≥35 before locally to lower MELD candidates. The characteristics and outcomes of local…
  • « Previous Page
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • …
  • 155
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences